- Home
- EQ vs THCH Comparison
EQ vs THCH Comparison
Compare EQ & THCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EQ
- THCH
- Stock Information
- Founded
- EQ 2017
- THCH 2018
- Country
- EQ United States
- THCH China
- Employees
- EQ N/A
- THCH N/A
- Industry
- EQ Biotechnology: Pharmaceutical Preparations
- THCH Blank Checks
- Sector
- EQ Health Care
- THCH Finance
- Exchange
- EQ Nasdaq
- THCH Nasdaq
- Market Cap
- EQ 85.1M
- THCH 84.2M
- IPO Year
- EQ 2018
- THCH N/A
- Fundamental
- Price
- EQ $1.39
- THCH $2.68
- Analyst Decision
- EQ Hold
- THCH
- Analyst Count
- EQ 2
- THCH 0
- Target Price
- EQ $1.00
- THCH N/A
- AVG Volume (30 Days)
- EQ 489.3K
- THCH 7.5K
- Earning Date
- EQ 11-11-2025
- THCH 11-12-2025
- Dividend Yield
- EQ N/A
- THCH N/A
- EPS Growth
- EQ N/A
- THCH N/A
- EPS
- EQ N/A
- THCH N/A
- Revenue
- EQ $16,553,000.00
- THCH $187,316,342.00
- Revenue This Year
- EQ N/A
- THCH N/A
- Revenue Next Year
- EQ N/A
- THCH N/A
- P/E Ratio
- EQ N/A
- THCH N/A
- Revenue Growth
- EQ N/A
- THCH N/A
- 52 Week Low
- EQ $0.27
- THCH $1.95
- 52 Week High
- EQ $2.35
- THCH $5.15
- Technical
- Relative Strength Index (RSI)
- EQ 48.48
- THCH 57.45
- Support Level
- EQ $1.31
- THCH $2.62
- Resistance Level
- EQ $1.58
- THCH $3.25
- Average True Range (ATR)
- EQ 0.13
- THCH 0.15
- MACD
- EQ 0.01
- THCH 0.02
- Stochastic Oscillator
- EQ 48.64
- THCH 33.72
About EQ Equillium Inc.
Equillium Inc is a clinical-stage biotechnology company engaged in developing novel therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory, disorders with high unmet medical need. The company intends to commercialize its product candidates either independently or through partnerships, or otherwise monetize its pipeline through strategic transactions. Itolizumab (EQ001), a clinical-stage product candidate, is an anti-CD6 immune-modifying monoclonal antibody, or mAb, that selectively targets the CD6-ALCAM signaling pathway to downregulate pathogenic T effector cells while preserving T regulatory cells critical for maintaining a balanced immune response. The company's other clinical-stage and pre-clinical-stage candidates include EQ101 and EQ302.
About THCH TH International Limited Ordinary shares
TH International Ltd is the parent company of the franchise of Tim Hortons coffee shops and has the rights to operate Tim Hortons coffee shops in mainland China, Hong Kong, and Macau. Through the Tim Hortons brand, the firm offers freshly brewed coffee, tea, and other beverages, bakery & sides, and sandwiches. The Company operated under single reportable segment, Tim Hortons. The company's revenue is derived from its operations in the PRC.